GlassScriptPhysician profile
Colleen C Saxton
NPI 1255301396
$1,873.44
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $310 · 2022: $541 · 2023: $625 · 2024: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $443.73 | 2021-2024 | Airsupra, Farxiga |
| Novo Nordisk INC | $365.39 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $256.33 | 2021-2023 | |
| Lilly USA, LLC | $210.20 | 2021-2024 | Mounjaro, Jardiance, Emgality |
| Glaxosmithkline, LLC. | $153.29 | 2021-2024 | Trelegy Ellipta, Shingrix |
| Pfizer INC. | $127.90 | 2021-2024 | |
| Alkermes, INC. | $42.63 | 2023 | Vivitrol |
| Janssen Pharmaceuticals, INC | $38.66 | 2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $36.16 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.20 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $24.26 | 2021-2022 | |
| Braeburn INC. | $20.31 | 2024 | Brixadi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.19 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.07 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.61 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.34 | 2023 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $14.96 | 2022 | |
| Phathom Pharmaceuticals, INC. | $14.90 | 2024 | Voquezna |
| Indivior INC. | $14.73 | 2022 | |
| Amarin Pharma, INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Saxton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.